Improving D‐2‐hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF‐receive/B 0 ‐shim array coils at 3 T-Reference-Cited by-同舟云学术

Improving D‐2‐hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF‐receive/B 0 ‐shim array coils at 3 T

Published:2021-10-05 Issue:1 Volume:35 Page:
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR in Biomedicine

Author:

Strasser Bernhard¹²,Arango Nicolas S.³,Stockmann Jason P.¹⁴,Gagoski Borjan⁵⁶,Thapa Bijaya¹,Li Xianqi¹,Bogner Wolfgang²^ORCID,Moser Philipp²,Small Julia⁷,Cahill Daniel P.⁷,Batchelor Tracy T.⁸,Dietrich Jorg⁸,Kouwe Andre¹⁴,White Jacob³,Adalsteinsson Elfar³⁹,Andronesi Ovidiu C.¹⁴^ORCID

Affiliation:

1. A. A. Martinos Center for Biomedical Imaging Massachusetts General Hospital, Radiology Boston Massachusetts USA

2. High‐Field MR Centre, Department of Biomedical Imaging and Image‐Guided Therapy Medical University of Vienna Vienna Vienna Austria

3. Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology Cambridge Massachusetts USA

4. Harvard Medical School Boston Massachusetts USA

5. Fetal Neonatal Neuroimaging and Developmental Science Center Boston Children's Hospital Boston Massachusetts USA

6. Department of Radiology Harvard Medical School Boston Massachusetts USA

7. Department of Neurosurgery Massachusetts General Hospital Boston Massachusetts USA

8. Department Neurology, Division of Neuro‐Oncology Massachusetts General Hospital Boston Massachusetts USA

9. Institute for Medical Engineering and Science Massachusetts Institute of Technology Cambridge Massachusetts USA

Funder

Austrian Science Fund

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nbm.4621

Reference51 articles.

1. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate

2. Volumetric relationship between 2‐Hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients;Jafari‐Khouzani K;Neuro Oncol.,2016

3. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate

4. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

5. Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in differential diagnosis of cerebrovascular diseases in magnetic resonance imaging: a narrative review;Quantitative Imaging in Medicine and Surgery;2023-04

2. Recapitulating the Key Advances in the Diagnosis and Prognosis of High-Grade Gliomas: Second Half of 2021 Update;International Journal of Molecular Sciences;2023-03-28